Abstract | AIM: To study the efficiency of using alfuzosin 10 mg (Alfuprost MR, SUN Pharma) in routine clinical practice in order to predict its feasibility for treating acute urinary retention. MATERIALS AND METHODS: RESULTS: CONCLUSIONS: Based on a prospective study, a high efficiency and safety of the Alfuprost MP 10 mg/day in patients with acute urinary retention was established.
|
Authors | A G Martov, D V Ergakov |
Journal | Urologiia (Moscow, Russia : 1999)
(Urologiia)
Issue 6
Pg. 58-63
(Dec 2020)
ISSN: 1728-2985 [Print] Russia (Federation) |
PMID | 33377680
(Publication Type: Journal Article)
|
Chemical References |
- Adrenergic alpha-Antagonists
- Quinazolines
- alfuzosin
|
Topics |
- Acute Disease
- Adrenergic alpha-Antagonists
- Aged
- Aged, 80 and over
- Humans
- Male
- Middle Aged
- Prospective Studies
- Prostatic Hyperplasia
(complications, drug therapy, surgery)
- Quinazolines
- Transurethral Resection of Prostate
- Urinary Retention
(drug therapy, etiology)
|